# Vertex Pharmaceuticals Inc / Ma: insider transactions

VRTX · Nasdaq · CIK 875320 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vrtx.md) · [Financials](/companies/vrtx/financials.md) · [Filings](/companies/vrtx/filings.md) · [Insiders](/companies/vrtx/insiders.md)

## All transactions: 1

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-20 | [Brennan Daniel J.](/insiders/1595612.md) | Director | Grant or award (A) | 795 | $503.47 | $400.3k | [Form 4](/filings/0000875320-26-000283.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.